# FDA UNTITLED_LETTER - Wedgewood Connect, LLC - November 17, 2023

Source: https://www.keypedia.com/records/untitled_letter/wedgewood-connect-llc/db7c4f87-7a7c-444c-9802-45f5228c2f61

> FDA UNTITLED_LETTER for Wedgewood Connect, LLC on November 17, 2023. Product: Drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: UNTITLED_LETTER
- Company Name: Wedgewood Connect, LLC
- Inspection Date: 2023-11-17
- Product Type: Drugs
- Office Name: Division of Pharmaceutical Quality Operations IV

## Related Documents

- [UNTITLED_LETTER - 2023-11-09](https://www.keypedia.com/records/untitled_letter/wedgewood-connect-llc/c7b71d6a-971e-480f-9e52-95939c6a80af)
- [483_RESPONSE - 2014-03-06](https://www.keypedia.com/records/483_response/wedgewood-connect-llc/4a7cbd55-5caa-4d18-8adc-862f1e5fb55f)
- [483 - 2021-12-03](https://www.keypedia.com/records/483/wedgewood-connect-llc/c7cc6b31-beb9-48a1-8899-6adcc3a25f2d)
- [483 - 2018-12-19](https://www.keypedia.com/records/483/wedgewood-connect-llc/9bf23e25-2dd6-4f6f-8404-6b1b89d277ae)
- [483_RESPONSE - 2023-11-17](https://www.keypedia.com/records/483_response/wedgewood-connect-llc/f7331f63-966b-46c2-9139-d427f1e0e9e1)

## Related Officers

- [Director - Compliance Branch](https://www.keypedia.com/people/lance-m-de-souza/8445cae5-3104-4159-89e9-e07fb7852270)

Company: https://www.keypedia.com/companies/wedgewood-connect-llc/26eedeaf-d44e-48a5-b4c3-8b28c9b361ff

Office: https://www.keypedia.com/offices/division-of-pharmaceutical-quality-operations-iv/a2d2ff91-dc0f-433e-b91f-ca90ff8998b6